Upgrade to SI Premium - Free Trial

Vivos Therapeutics (VVOS)

0.16 -0.02 (11.11%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/18/26)

Latest Headlines

Vivos Therapeutics cuts debt by exchanging shares with creditor September 8, 2026 8:45 AM - StreetInsider Vivos Therapeutics Announces Material Debt Reduction September 8, 2026 8:45 AM - StreetInsider Vivos Therapeutics to Present at the 2026 Moody Capital Solutions Disruptive Growth & Life Sciences Conference September 1, 2026 8:02 AM - StreetInsider New to The Street Broadcasting Today at 6:30 PM EST on Bloomberg Television Across the U.S., Latin America and MENA-Featuring FreeCast (NASDAQ: CAST), Metaterra Holdings (MTHI) and SafeSpace Global (S August 29, 2026 9:23 AM - StreetInsider Vivos Therapeutics signs deal for Florida sleep center with cardiologists August 28, 2026 8:45 AM - StreetInsider Vivos Therapeutics and South Palm Cardiovascular Associates Sign Definitive Agreements to Launch Regional Sleep Testing and Treatment Center August 28, 2026 8:45 AM - StreetInsider Form 4 Vivos Therapeutics, Inc. For: Jul 31 Filed by: Amman Bradford K. August 26, 2026 4:10 PM - SEC Filing Vivos Therapeutics reports 212% rise in Nevada patient referrals August 25, 2026 8:45 AM - StreetInsider Vivos Therapeutics Reports Record New Patient Referrals at its Nevada Sleep & Airway Medicine Centers August 25, 2026 8:45 AM - Globe NewsWire Vivos Therapeutics Reports Record New Patient Referrals at its Nevada Sleep & Airway Medicine Centers August 25, 2026 8:45 AM - StreetInsider Form 8-K Vivos Therapeutics, Inc. For: Aug 20 August 21, 2026 5:30 PM - SEC Filing Vivos Therapeutics opens sleep center in Henderson, Nevada August 20, 2026 10:24 AM - StreetInsider Vivos Therapeutics Opens New Sleep Testing and Treatment Facility in Nevada to Meet Rapidly Growing Patient Demand for Sleep Apnea Testing and Treatment August 20, 2026 10:24 AM - Globe NewsWire Vivos Therapeutics (VVOS) Tops Q2 EPS by 6c August 17, 2026 6:16 AM - StreetInsider Vivos Therapeutics posts 35% revenue gain but widens net loss August 14, 2026 4:29 PM - StreetInsider Vivos Therapeutics Reports Second Quarter 2026 Financial Results and Provides Operational Update August 14, 2026 4:29 PM - Globe NewsWire Form 10-Q Vivos Therapeutics, Inc. For: Jun 30 August 14, 2026 4:13 PM - SEC Filing Form SCHEDULE 13G/A Vivos Therapeutics, Inc. Filed by: ARMISTICE CAPITAL, LLC August 14, 2026 10:30 AM - SEC Filing Vivos Therapeutics Schedules Release of Second Quarter 2026 Financial Results and Conference Call August 14, 2026 8:45 AM - StreetInsider Form 8-K Vivos Therapeutics, Inc. For: Aug 05 August 11, 2026 5:03 PM - SEC Filing Form SCHEDULE 13G Vivos Therapeutics, Inc. Filed by: Streeterville Capital LLC August 11, 2026 1:28 PM - SEC Filing Vivos Therapeutics expands AI platform deal with Greenway Health August 11, 2026 8:49 AM - StreetInsider Vivos Therapeutics Expands Greenway Health Partnership to Deploy AI-Enabled Platform Across All Clinical and Revenue Operations August 11, 2026 8:45 AM - StreetInsider Vivos Therapeutics Announces Issuance of New US Patent Broadening Protection for Its Vivos CARE Oral Medical Device Technology August 5, 2026 8:30 AM - StreetInsider Form 8-K Vivos Therapeutics, Inc. For: Jul 31 August 3, 2026 5:29 PM - SEC Filing Form SCHEDULE 13D Vivos Therapeutics, Inc. Filed by: V-Co Investors 4 LLC July 15, 2026 5:07 PM - SEC Filing Form 4 Vivos Therapeutics, Inc. For: Jun 30 Filed by: Skaff Michael C July 15, 2026 4:24 PM - SEC Filing Form 3 Vivos Therapeutics, Inc. For: Jun 30 Filed by: V-Co Investors 4 LLC July 15, 2026 4:22 PM - SEC Filing Form 8-K Vivos Therapeutics, Inc. For: Jul 07 July 7, 2026 5:30 PM - SEC Filing Vivos reports insomnia improvement in small Vida appliance study June 30, 2026 8:46 AM - StreetInsider Vivos’ Vida® Appliance Shows Statistically Significant Improvement in Insomnia Severity in 100% of Study Participants June 30, 2026 8:45 AM - StreetInsider Form 8-K Vivos Therapeutics, Inc. For: Jun 25 June 25, 2026 5:22 PM - SEC Filing Vivos Therapeutics extends Streeterville debt conversion deal to August June 22, 2026 8:30 AM - StreetInsider Vivos Therapeutics and Streeterville Extend Timeframe of Strategic Financing Agreement and Reaffirm Commitment to Convert Debt Into Common Stock and Perpetual Preferred Equity June 22, 2026 8:30 AM - StreetInsider Full Article List